Gastrectomy, Peritonectomy, and Perioperative Intraperitoneal Chemotherapy: The Evolution of Treatment Strategies for Advanced Gastric Cancer

Seminars in Surgical Oncology

Volumn 21, Issue 4, 2003, Pages 233-248

  Sugarbaker, Paul H ^a   Yu, Wansik ^b   Yonemura, Yutaka ^c  

^a WASHINGTON CANCER INSTITUTE   (United States)

^b Kyungpook National University Hospital   (South Korea)

^c SHIZUOKA CANCER CENTER   (Japan)

Author keywords

5 fluorouracil; Gastric cancer; Intraperitoneal chemotherapy; Lymphadenectomy; Mitomycin C; Peritonectomy

Indexed keywords

ANTINEOPLASTIC AGENT; MISONIDAZOLE; MITOMYCIN C;

CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; CARCINOMATOSIS; GASTRECTOMY; HUMAN; METASTASIS; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; STOMACH CARCINOMA; SURGICAL TECHNIQUE; TREATMENT PLANNING;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; GASTRECTOMY; HUMANS; INFUSIONS, PARENTERAL; NEOPLASM SEEDING; PALLIATIVE CARE; PERITONEAL NEOPLASMS; PERITONEUM; STOMACH NEOPLASMS;

EID: 0346123206     PISSN: 87560437     EISSN: None     Source Type: Journal    
DOI: 10.1002/ssu.10042     Document Type: Review

References (71)

1. Akoh JA, Macintyre IM: Improving survival in gastric cancer: review of 5-year survival rates in English language publications from 1970. Br J Surg 1992;79:293-299.
2. Hermans J, Bonenkamp JJ, Boon MC et al: Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomizec trials. J Clin Oncol 1993;11:1441-1447.
3. Lise M, Nitti D, Marchet A, et al: Final results of a phase III clinical trial of adjuvant chemotherapy with modified fluorouracil, doxorubicin, and mitomycin regimen in resectable gastric cancer. J Clin Oncol 1995;13:2757-2763.
4. Hallisay MT, Dunn JA, Ward LC, et al: The second British stomach cancer group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: five-year follow-up, Lancet 1994;343:1309-1312.
5. Wanebo HJ, Kennedy BJ, Chmiel J, et al: Cancer of the stomach: a patient care study by the American College of Surgeons. Ann Surg 1993;218:583-593.
6. Gunderson LL, Sosin H: Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look), clinico-pathologic correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 1992;8:1-11.
7. Wisbeck WM, Becheer EM, Russell AH: Adenocarcinoma of the stomach: autopsy observations with therapeutic implications for the radiation oncologist. Radiother Oncol 1986;7:13-18.
8. Landry J, Tepper JE, Wood WC, et al: Patterns of failure following curative resection of gastric carcinoma. Int J Radiat Oncol Biol Phys 1990;1357-1362.
9. Bruckner HW, Stablein DM: Sites of treatment failure: gastrointestinal tumor study group analyses of gastric, pancreatic, and colorectal trials. Cancer Treat Symp 1983;2:199-210.
10. Wils J, Meyer H-J, Wilke H: Current status and future directions in the treatment of localized gastric cancer. Oncology 1994;5(Suppl 3):69-72.
11. Maruyama K, Okabayashi K, Kinoshita T: Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg 1987;11:418-425.
12. Kaibara N, Sumi K, Yonekawa, et al: Does extensive dissection of lymph nodes improve the results of surgical treatment of gastric cancer? Am J Surg 1990;159:218-221.
13. Korenaga D, Moriguchi S, Orita H, et al: Trends in survival rates in Japanese patients with advanced carcinoma of the stomach. Surg Gynecol Obstet 1992;174:387-393.
14. Boku T, Nakane Y, Minoura, et al: Prognostic significance of serosal invasion and free intraperitoneal cancer cells in gastric cancer. Br J Surg 1990;77:436-439.
15. Fujimura T, Yonemura Y, Ninomiya I, et al: Early detection of peritoneal dissemination of gastrointestinal cancers by reverse-transcriptase polymerase chain reaction. Oncol Rep 1997;4:1015-1019.
16. Kodera Y, Yamamura Y, Shimizu Y, et al: Peritoneal washing cytology: prognostic value of positive findings in patients with gastric carcinoma undergoing a potentially curative resection. J Surg Oncol 1999;72:60-65.
17. Bando E, Yonemura Y, Takeshita Y, et al: Intraoperative lavage for cytological examination in 1,297 patients with gastric carcinoma. Am J Surg 1999;178:256-262.
18. Koga S, Hamazoe R, Maeta M, et al: Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C. Cancer 1998;61:232-237.
19. Hamazoe R, Maeta M, Kaibara N: Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Cancer 1994;73:2048-2052.
20. Fujimura T, Yonemura Y, Muraoka K, et al: Continuous hyperthermic peritoneal perfusion for the prevention of peritoneal recurrence of gastric cancer: randomized controlled study. World J Surg 1994;18:150-155.
21. Yonemura Y, Ninomiya I, Kaji M, et al: Prophylaxis with intraoperative chemohyperthermia against peritoneal recurrence of serosal invasion-positive gastric cancer. World J Surg 1995;19:450-455.
22. Ikeguchi M, Kondou A, Oka A, et al: Effects of continuous hyperthermic peritoneal perfusion on prognosis of gastric cancer with serosal invasion. Eur J Surg 1995;161:581-586.
23. Yu W, Whang I, Suh I, et al: Prospective randomized trial of early postoperative intraperitoneal chemotherapy as an adjuvant to resectable gastric cancer. Ann Surg 1998;228:347-354.
24. Fujimoto S, Takahashi M, Mutou T, et al: Successful intraperitoneal hyperthermic chemoperfusion for the prevention of post-operative peritoneal recurrence in patients with advanced gastric cancer. Cancer 1999;85:529-534.
25. Kim JY, Rhew CH, Kim KS, Jeong JH: Controlled clinical trial for the gastric carcinoma patients who underwent surgery plus IHCP. Proceedings of the Third International Gastric Cancer Congress; 1999 April 27-30; Seoul, Korea. p. 106.
26. Sautner T, Hofbauer F, Depisch D, et al: Adjuvant intraperitoneal cisplatin chemotherapy does not improve long-term survival after surgery for advanced gastric cancer. J Clin Oncol 1994;12:970-974.
27. Cunliffe WJ, Sugarbaker PH: Gastrointestinal malignancy: rationale for adjuvant therapy using early postoperative intraperitoneal chemotherapy. Br J Surg 1989;76:1082-1090.
28. Sugarbaker PH, Graves T, DeBruijn EA, et al: Rationale for early postoperative intraperitoneal chemotherapy (EPIC) in patients with advanced gastrointestinal cancer. Cancer Res 1990;50:5790-5794.
29. Averbach AM, Sugarbaker PH: Methodological consider in treatment using intraperitoneal chemotherapy. In Sugarbaker PH (ed): "Peritoneal carcinomatosis: principles of management." Boston: Kluwer; 1996. p. 289-310.
30. Preusser P, Wilke H, Achterrath W, et al: Phase II study with the combination of etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer. J Clin Oncol 1989;7:1310-1317.
31. Ajani JA, Ota DM, Jessup JM, et al: Resectable gastric carcinoma: an evaluation of preoperative and postoperative chemotherapy. Cancer 1991;68:1501-1506.
32. Lawrence W. McNeer G: The effectiveness of surgery for palliation of incurable gastric cancer. Cancer 1958;1:23-32.
33. Stern JL, Denman S, Elias EG, et al: Evaluation of palliative resection in advanced carcinoma of the stomach. Surgery 1975;77:291-298.
34. Ekbom GA, Gleysteen JJ: Gastric malignancy: resection for palliation. Surgery 1980;88:476-481.
35. Gastrointestinal Tumor Study Group: A comparison of combination chemotherapy and combined modality therapy for locally advanced gastric carcinoma. Cancer 1982;49:1771-1777.
36. Meijer S, De Bakker OJ, Hoitsma HF: Palliative resection in gastric cancer. J Surg Oncol 1983;23:77-80.
37. Boddie AW, McMurtrey MJ, Giacco GG, McBride CM: Palliative total gastrectomy and esophagogastrectomy: a reevaluation. Cancer 1983;51:1195-1200.
38. Bozzetti F, Bonfanti G, Audisio RA, et al: Prognosis of patients after palliative surgical procedures for carcinoma of the stomach. Surg Gynecol Obstet 1987;164:151-154.
39. Hallisey MT, Allum WH, Roginski C, Fielding JW: Palliative surgery for gastric cancer. Cancer 1988;62:440-444.
40. Butler JA, Dubrow TJ, Trezona T, et al: Total gastrectomy in the treatment of advanced gastric cancer. Am J Surg 1989;158:602-605.
41. Haugstvedt T, Viste A, Eide G, Soreide O: The survival benefit of resection in patients with advanced stomach cancer: the Norwegian multicenter experience. World J Surg 1989;13:616-622.
42. Monson JR, Donohue JH, McIlrath DC, et al: Total gastrectomy for advanced cancer: a worthwhile palliative procedure. Cancer 1991;68:1863-1868.
43. ReMine WH: Palliative operations for incurable gastric cancer. World J Surg 1979;3:721-729.
44. Ouchi K, Sugawara T, Ono H, et al: Therapeutic significance of palliative operations for gastric cancer for survival and quality of life. J Surg Oncol 1998;69:41-44.
45. Kikuchi S, Arai Y, Morise M, et al: Gastric cancer with metastases to the distant peritoneum: a 20-year surgical experience. Hepatogastroenterology 1998;45:1183-1188.
46. Isozaki H, Okajima K, Kawashima Y, et al: Relative non-curative resection of gastric cancer: a review of 106 cases. Jpn J Cancer Clin 1993;39:657-662.
47. Maekawa S, Saku M, Maehara Y, et al: Surgical treatment for advanced gastric cancer. Hepatogastroenterology 1996;43:178-186.
48. Bae BJ, Park KH, Sohn SS, et al: Prognosis of the patients with stage IV gastric cancer. In Siewert JR, Roder JD (eds). Proceedings of the 2nd International Gastric Cancer Congress, Munich, Germany. Bologna: Monduzzi; 1997. p. 175-179.
49. Sugarbaker PH: Peritonectomy procedures. In Sugarbaker PH (ed): "Peritoneal carcinomatosis: principles of management." Boston: Kluwer; 1996. p. 235-253.
50. Sugarbaker PH, Averbach AM, Stephens AD: Gastric cancer with peritoneal carcinomatosis: case report and presentation of a pilot treatment plan. Surg Rounds 1996;19:14-21.
51. Yonemura Y, Fujimura T, Fushida S, et al: Techniques of peritonectomy for advanced and recurrent gastric cancer with peritoneal dissemination. In Siewert JR, Roder JD (eds). Proceedings of the 2nd International Gastric Cancer Congress, Munich, Germany. Bologna: Monduzzi; 1997. p. 1365-1369.
52. Yonemura Y, Fujimura T, Fushida S, et al: A new surgical approach (peritonectomy) for the treatment of peritoneal dissemination. Hepatogastroenterology 1999;46:601-609.
53. Fushida S, Nakagawara H, Miyazaki I: Peritonectomy for advanced gastric cancer. In Yonemura Y (ed): "Peritoneal dissemination-molecular mechanisms and latest therapy." Maeda: Kanazawa; 1998. p. 275-293.
54. Hagiwara A, Sawai K, Sakakura C, et al: Complete omentectomy and extensive lymphadenectomy with gastrectomy improves the survival of gastric cancer patients with metastases in the adjacent peritoneum. Hepatogastroenterology 1998;45:1922-1929.
55. Yonemura Y, Fujimura T, Nishimura G, et al: Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination. Surgery 1996;119:437-444.
56. Fujimoto S, Shrestha RD, Kokubun M, et al: Clinical outcome of combined therapy on intraoperative hyperthermochemotherapy and surgery for patients with peritoneal recurrence from gastric cancer. Reg Cancer Treat 1990;3:181-184.
57. Hirose K, Katayama K, Iida A, et al: Efficacy of continuous hyperthermic peritoneal perfusion for the prophylaxis and treatment of peritoneal metastasis of advanced gastric cancer: evaluation by multivariate regression analysis. Oncology 1999;57:106-114.
58. Yoo CH, Noh SH, Shin DW, et al: Early postoperative intraperitoneal chemotherapy (EPIC) for advanced gastric cancer. Proceedings of the 3rd International Gastric Cancer Congress; 1999 April 27-30; Seoul, Korea. p. 103.
59. Fujimoto S, Shrestha RD, Kokubun M, et al: Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding. Ann Surg 1988;208:36-41.
60. Fujimoto S, Shrestha RD, Kokubun, M, et al: Positive results of combined therapy of surgery and intraperitoneal hyperthermic perfusion for far-advanced gastric cancer. Ann Surg 1989;212:592-596.
61. Fujimura T, Yonemura Y, Fushida S, et al: Continuous hyperthermic peritoneal perfusion for the treatment of peritoneal dissemination in gastric cancers and subsequent second-look operation. Cancer 1990;65:65-71.
62. Yonemura Y, Fujimura T, Fushida S, et al: Hyperthermochemotherapy combined with cytoreductive surgery for the treatment of gastric cancer with peritoneal dissemination. World J Surg 1991;15:530-536.
63. Noh SH, Son BH, Min JS: Treatment of gastric cancer with peritoneal metastasis. J Korean Surg Soc 1995;49:77-83.
64. Yonemura Y, Ninomiya I, Kaji M, et al: Prophylaxis with intraoperative chemohyperthermia against peritoneal recurrence of serosal invasion-positive gastric cancer. World J Surg 1995;19:450-455.
65. Yonemura Y, Fujimura T, Fushida S, et al: A novel treatment for the peritoneal dissemination of gastric cancer. Peritonectomy and hyperthermo-chemotherapy. In Nishi M, Sugano H, Takahashi T (eds). Proceedings of the International Gastric Cancer Congress, Munich, Germany. Bologna: Monduzzi; 1995. p. 1673-1676.
66. Hirose K, Katayama K, Iida A, et al: Efficacy of continuous hyperthermic peritoneal perfusion for the prophylaxis and treatment of peritoneal metastasis of advanced gastric cancer: evaluation by multivariate regression analysis. Oncology 1999;57:106-114.
67. Fujimura T, Yonemura Y, Muraoka K, et al: Continuous hyperthermic peritoneal perfusion for the prevention of peritoneal recurrence of gastric cancer: randomized controlled study. World J Surg 1994;18:150-155.
68. Sugarbaker PH, Averbach AM, Jacquet P, et al: A simplified approach to hyperthermic intraoperative intraperitoneal chemotherapy (HIIC) using a self retaining retractor. In Sugarbaker PH (ed): "Peritoneal carcinomatosis: principles of management." Boston: Kluwer; 1996. p. 415-421.
69. Stephens AD, Alderman R, Chang D, et al: Morbidity and mortality of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the Coliseum technique. Ann Surg Oncol 1999;6:790-796.
70. Gomez Portilla A, Sugarbaker PH, Chang D: Second-look surgery after cytoreductive and intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer: analysis of prognostic features. World J Surg 1999;23:23-29.
71. Berthet B, Sugarbaker TA, Chang D, Sugarbaker PH: Quantitative methodologies for selection of patients with recurrent abdominopelvic sarcoma for treatment. Eur J Cancer 1999;35:413-419.